SLC6 Neurotransmitter Transporters: Structure, Function, and Regulation
Top Cited Papers
- 13 July 2011
- journal article
- review article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Pharmacological Reviews
- Vol. 63 (3), 585-640
- https://doi.org/10.1124/pr.108.000869
Abstract
The neurotransmitter transporters (NTTs) belonging to the solute carrier 6 (SLC6) gene family (also referred to as the neurotransmitter-sodium-symporter family or Na+/Cl−-dependent transporters) comprise a group of nine sodium- and chloride-dependent plasma membrane transporters for the monoamine neurotransmitters serotonin (5-hydroxytryptamine), dopamine, and norepinephrine, and the amino acid neurotransmitters GABA and glycine. The SLC6 NTTs are widely expressed in the mammalian brain and play an essential role in regulating neurotransmitter signaling and homeostasis by mediating uptake of released neurotransmitters from the extracellular space into neurons and glial cells. The transporters are targets for a wide range of therapeutic drugs used in treatment of psychiatric diseases, including major depression, anxiety disorders, attention deficit hyperactivity disorder and epilepsy. Furthermore, psychostimulants such as cocaine and amphetamines have the SLC6 NTTs as primary targets. Beginning with the determination of a high-resolution structure of a prokaryotic homolog of the mammalian SLC6 transporters in 2005, the understanding of the molecular structure, function, and pharmacology of these proteins has advanced rapidly. Furthermore, intensive efforts have been directed toward understanding the molecular and cellular mechanisms involved in regulation of the activity of this important class of transporters, leading to new methodological developments and important insights. This review provides an update of these advances and their implications for the current understanding of the SLC6 NTTs.Keywords
This publication has 682 references indexed in Scilit:
- Interaction Between the Serotonin Transporter Gene (5-HTTLPR), Stressful Life Events, and Risk of DepressionJAMA, 2009
- Modeling rare gene variation to gain insight into the oldest biomarker in autism: construction of the serotonin transporter Gly56Ala knock-in mouseJournal of Neurodevelopmental Disorders, 2009
- Dopamine spillover after quantal release: Rethinking dopamine transmission in the nigrostriatal pathwayBrain Research Reviews, 2008
- Structural determinants of species‐selective substrate recognition in human and Drosophila serotonin transporters revealed through computational docking studiesProteins, 2008
- Synthesis and monoamine transporter binding properties of 2β-[3′-(substituted benzyl)isoxazol-5-yl]- and 2β-[3′-methyl-4′-(substituted phenyl)isoxazol-5-yl]-3β-(substituted phenyl)tropanesBioorganic & Medicinal Chemistry, 2008
- The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disordersJournal of Neural Transmission, 2008
- Turnover Rate of the γ-Aminobutyric Acid Transporter GAT1The Journal of Membrane Biology, 2007
- Cause-Specific Excess Deaths Associated With Underweight, Overweight, and ObesityJAMA, 2007
- Dopamine and depressionJournal of Neural Transmission, 1993
- Steady states, charge movements, and rates for a cloned GABA transporter expressed in Xenopus oocytesNeuron, 1993